Skip to main content

Table 2 The general information of rats in each group before cells treatment (X ± S)

From: Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model

Time point Control DM BMSCs Ad-null-BMSCs Ad-ILK-BMSCs
Body weight (g)
 Before modeling 189 ± 11.7 178 ± 12.5 171 ± 8.6 184 ± 10.9 176 ± 9.6
 10th week 394 ± 18.1 167 ± 20.4 163 ± 15.9 164 ± 13.7 159 ± 18.5
 14th week 503 ± 37.2 162 ± 26.8 160 ± 27.8 162 ± 19.1 157 ± 24.1
Blood glucose level (mM)
 First week 4.7 ± 0.68 22.5 ± 3.8 22.9 ± 4.9 21.8 ± 4.1 23.6 ± 3.6
 14th week 5.1 ± 0.41 24.1 ± 4.2 23.8 ± 3.3 23.1 ± 4.7 22.8 ± 4.8
  1. S standard deviation, X X-bar